Circulating Tumor Cells (CTCS) as Prognostic Biomarker in Patients with Advanced Chemorefractory, Ras Wild-Type Colorectal Cancer (CRC) Treated with Cetuximab or Panitumumab
Titel:
Circulating Tumor Cells (CTCS) as Prognostic Biomarker in Patients with Advanced Chemorefractory, Ras Wild-Type Colorectal Cancer (CRC) Treated with Cetuximab or Panitumumab
Auteur:
Musella, V. Pietrantonio, F. Di Buduo, E. Bossi, I. Iacovelli, R. Maggi, C. Martinetti, A. Sottotetti, E. Di Bartolomeo, M. de Braud, F. Cappelletti, V.